ZFP106, or Zinc Finger Protein 106, serves a multifunctional role within cellular biology, underscored by its involvement in DNA binding, transcriptional regulation, and potentially in the repair and maintenance of neural and muscle tissue. As a member of the zinc finger protein family, ZFP106 is characterized by its ability to bind DNA through zinc finger motifs, which facilitate its interaction with specific DNA sequences to regulate the transcription of target genes. This regulatory capacity is crucial for various developmental processes and the maintenance of cellular homeostasis. The breadth of ZFP106's functionality suggests its participation in complex cellular pathways, including those related to the differentiation of cells, response to cellular stress, and the regulation of metabolic processes. Given the protein's implication in neural and muscular systems, ZFP106's proper function is likely essential for the health and maintenance of these tissues, pointing towards its significance in understanding diseases that affect these systems.
The activation of ZFP106 involves intricate regulatory mechanisms that ensure its function is precisely coordinated with cellular needs. Post-translational modifications (PTMs), such as phosphorylation, sumoylation, or ubiquitination, play a vital role in modulating the activity, stability, and subcellular localization of ZFP106. These modifications can act as switches that enable or enhance ZFP106's DNA-binding affinity, influence its interaction with other transcriptional regulators, or dictate its participation in specific signaling pathways. Furthermore, the cellular context, including the presence of co-factors or specific signaling molecules, can dictate the activation state of ZFP106. For instance, interactions with other proteins could promote the formation of a transcriptional complex, facilitating the transcriptional regulation of genes involved in neural and muscle function. Such mechanisms highlight the complexity of ZFP106's role in the cell, where its activation is finely tuned by a network of signaling pathways and PTMs, underscoring the protein's adaptability and importance in cellular physiology and the response to physiological challenges.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
1-Hydroxypyridine-2-thione zinc salt can increase the binding affinity of zinc finger proteins like ZFP106 to DNA by increasing the local concentration of zinc, which is crucial for the structural integrity of the zinc finger motifs. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, thereby activating PKA. PKA phosphorylation can enhance the activity of ZFP106 by modifying its conformation or interaction with other proteins and DNA. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This DNA methyltransferase inhibitor may upregulate genes that are silenced by methylation, potentially including the gene for ZFP106, indirectly enhancing its functional activity by increasing its availability. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, as an HDAC inhibitor, may improve ZFP106 function by facilitating a more open chromatin state, improving the binding of ZFP106 to its target DNA sequences. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, another HDAC inhibitor, can enhance the transcriptional activity of ZFP106 by increasing histone acetylation levels and thus improving the transcription factor's access to DNA. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid influences gene expression and could indirectly increase ZFP106 activity by activating genes that are downstream targets or are involved in the same pathways as ZFP106. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and potentially enhance the activity of transcription factors like ZFP106. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can inhibit DNA methyltransferases, potentially upregulating genes silenced by methylation, including possibly ZFP106, thus enhancing its functional activity. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol upregulates the transcription of estrogen-responsive genes which could include ZFP106 or its targets, leading to an enhancement of ZFP106 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3, which may enhance ZFP106 activity by preventing the phosphorylation and degradation of proteins that interact with or regulate ZFP106 function. | ||||||